HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

James T Rosenbaum Selected Research

Blau syndrome

6/2009NOD2-associated pediatric granulomatous arthritis, an expanding phenotype: study of an international registry and a national cohort in Spain.
2/2009The NOD2 defect in Blau syndrome does not result in excess interleukin-1 activity.
1/2008Uveitis secondary to bacterial products.
3/2006Human endothelial cells express NOD2/CARD15 and increase IL-6 secretion in response to muramyl dipeptide.
2/2005Blau syndrome mutation of CARD15/NOD2 in sporadic early onset granulomatous arthritis.
10/2003With a mere nod, uveitis enters a new era.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


James T Rosenbaum Research Topics

Disease

69Uveitis
01/2022 - 09/2002
61Inflammation (Inflammations)
01/2022 - 04/2003
18Sarcoidosis (Schaumann Disease)
01/2022 - 11/2003
17Anterior Uveitis
01/2022 - 07/2002
11Scleritis (Episcleritis)
01/2022 - 10/2006
11Ankylosing Spondylitis
10/2021 - 11/2004
11Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2021 - 11/2007
9Eye Diseases (Eye Disease)
10/2020 - 04/2003
9Arthritis (Polyarthritis)
02/2016 - 10/2003
8Intermediate Uveitis (Chronic Cyclitis)
01/2021 - 08/2006
8Panuveitis
01/2021 - 11/2009
7Neoplasms (Cancer)
12/2017 - 09/2002
6Cataract (Cataracts)
01/2022 - 11/2012
6Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
01/2022 - 12/2009
6Macular Edema
01/2021 - 06/2002
6Posterior Uveitis
01/2021 - 06/2007
6Blau syndrome
06/2009 - 10/2003
5Graves Ophthalmopathy
12/2021 - 01/2015
5Axial Spondyloarthritis
10/2021 - 01/2017
5Psoriasis (Pustulosis Palmaris et Plantaris)
05/2020 - 05/2010
5Necrosis
01/2015 - 05/2003
5Spondylarthropathies
03/2014 - 02/2010
4Retinal Vasculitis
12/2021 - 06/2012
4Psoriatic Arthritis
05/2020 - 01/2014
4Crohn Disease (Crohn's Disease)
01/2020 - 11/2007
3Glaucoma
12/2021 - 12/2015
3Diabetic Retinopathy (Retinopathy, Diabetic)
12/2021 - 10/2007
3Rheumatic Diseases (Rheumatism)
04/2021 - 05/2010
3Dysbiosis
10/2020 - 01/2016
3Vasculitis (Vasculitides)
01/2019 - 12/2009
3Retinal Detachment (Retinal Detachments)
03/2016 - 11/2012
3Iritis
02/2016 - 11/2004
3Granuloma
01/2015 - 04/2009
3Edema (Dropsy)
12/2012 - 07/2009
3Autoimmune Diseases (Autoimmune Disease)
01/2012 - 04/2007
3Bullous Pemphigoid (Pemphigoid)
03/2010 - 10/2009
3Lymphoma (Lymphomas)
04/2007 - 09/2002
2Band-Shaped Corneal Dystrophy
01/2022 - 11/2012
2Orbital Diseases
01/2022 - 05/2014
2Rheumatoid Arthritis
12/2021 - 01/2020
2Pulmonary Sarcoidosis
01/2021 - 01/2012
2Birdshot Chorioretinopathy
10/2020 - 07/2019

Drug/Important Bio-Agent (IBA)

32Adrenal Cortex Hormones (Corticosteroids)IBA
01/2022 - 07/2005
18Retinaldehyde (Retinal)IBA
12/2021 - 12/2002
12HLA-B27 Antigen (HLA B27 Antigen)IBA
10/2021 - 05/2007
12CytokinesIBA
04/2021 - 03/2006
12Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2018 - 07/2002
10Immunosuppressive Agents (Immunosuppressants)IBA
04/2016 - 07/2005
9Prednisone (Sone)FDA LinkGeneric
01/2021 - 10/2009
8Adalimumab (Humira)FDA Link
01/2021 - 10/2007
8AntigensIBA
05/2020 - 04/2005
7Tumor Necrosis Factor InhibitorsIBA
01/2020 - 10/2007
7Infliximab (Remicade)FDA Link
05/2016 - 07/2005
6Biological ProductsIBA
01/2018 - 04/2007
6Monoclonal AntibodiesIBA
05/2016 - 04/2013
6Methotrexate (Mexate)FDA LinkGeneric
04/2015 - 09/2002
6OvalbuminIBA
01/2013 - 01/2006
6EndotoxinsIBA
03/2012 - 05/2003
5AntibodiesIBA
12/2021 - 04/2005
5Interleukin-17 (Interleukin 17)IBA
04/2021 - 04/2009
5Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
01/2019 - 04/2005
5HLA Antigens (Human Leukocyte Antigens)IBA
01/2017 - 02/2003
5ChemokinesIBA
01/2015 - 02/2003
5AntimetabolitesIBA
03/2014 - 01/2008
4Messenger RNA (mRNA)IBA
01/2021 - 02/2003
4RNA (Ribonucleic Acid)IBA
01/2021 - 01/2015
4Interleukin-23 (Interleukin 23)IBA
01/2020 - 01/2011
4LipopolysaccharidesIBA
11/2019 - 01/2008
4Fluorescein (Funduscein)FDA LinkGeneric
01/2019 - 07/2005
4InterferonsIBA
01/2018 - 08/2009
4Mycophenolic Acid (Cellcept)FDA LinkGeneric
01/2014 - 12/2008
4Azathioprine (Imuran)FDA LinkGeneric
01/2014 - 12/2008
4InterleukinsIBA
05/2012 - 04/2009
4Proteins (Proteins, Gene)FDA Link
04/2009 - 10/2003
3Chemokine ReceptorsIBA
04/2021 - 04/2007
3SteroidsIBA
01/2021 - 01/2015
3Biomarkers (Surrogate Marker)IBA
01/2021 - 04/2005
3Peptides (Polypeptides)IBA
01/2019 - 10/2011
3Interleukin-1 (Interleukin 1)IBA
01/2018 - 02/2009
3Rituximab (Mabthera)FDA Link
05/2016 - 05/2014
3Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
02/2016 - 04/2007
3Formaldehyde (Formol)FDA Link
10/2015 - 02/2007
3ParaffinIBA
10/2015 - 02/2007
3Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2014 - 07/2009
3Peptidoglycan (Murein)IBA
07/2011 - 04/2010
3NucleotidesIBA
04/2010 - 10/2003
3LigandsIBA
03/2010 - 03/2006
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2010 - 12/2008
3Alkylating AgentsIBA
07/2009 - 01/2008
2Hydroxychloroquine (Plaquenil)FDA LinkGeneric
12/2021 - 01/2021
2Immunoglobulin G (IgG)IBA
12/2021 - 01/2014

Therapy/Procedure

45Therapeutics
01/2021 - 07/2002
5Injections
01/2021 - 06/2002
5Vitrectomy
01/2018 - 11/2012
4Aftercare (After-Treatment)
12/2017 - 04/2007
3Transplantation
01/2022 - 07/2009
3Intravitreal Injections
12/2019 - 06/2005
3Biological Therapy
10/2018 - 11/2010
3Intraocular Injections
11/2014 - 03/2012
3Slit Lamp
01/2012 - 01/2008